StocksVertex Pharmaceuticals IncorporatedVRTX

VRTX

Vertex Pharmaceuticals Incorporated

276.24 2.73 (1.00%)
Prezzi ritardati da NASDAQ, in USD Mercato aperto
Investi
S
276.24
B
277.11
Fissare il Post
Genome Engineering
Vertex, Verve team up to develop a gene editing drug for liver disease 🔹 $VRTX (Vertex Pharmaceuticals Incorporated) is broadening its reach in gene editing, announcing Wednesday a deal with $VERV (Verve Therapeutics Inc) to develop a one-time treatment for an undisclosed liver disease. Vertex will... Mostra di più Traduci
Feed Mercati
Top
NathanClarke2022
Matejbod
July -4,03 Definitely unhappy about the results. Couple times I wrongly assessed the situation. Now I will be looking for the best possible exit points from those equities. $QURE (uniQure NV) $RBLX (Roblox Corp.) $VEEV (Veeva Systems Inc A) $SHLS (Shoals Technologies Group Inc) As always. I am still... Mostra di più Traduci
NathanClarke2022
Cancer-Med
Dear Investors, Here is your monthly update for June 2022. Global financial markets continued to struggle over the course of the month as the U.S. Federal Reserve took a more hawkish approach and geopolitical tensions remain. The S&P 500 Index capped its worst first since 1970. 💭 Find out more about... Mostra di più Traduci
Genome Engineering
Dear Investors, Here is your monthly update for June 2022. Global financial markets continued to struggle over the course of the month as the U.S. Federal Reserve took a more hawkish approach and geopolitical tensions remain. The S&P 500 Index capped its worst first since 1970. 💭 Find out more about... Mostra di più Traduci